ストックスクリーナーアプリを入手
7.88
0.51%
0.04
前日終値:
$7.84
開ける：
$7.8
24時間の取引高:
262.71K
Relative Volume:
2.61
時価総額：
$221.56M
収益：
$21.25M
当期純損益:
$-16.05M
株価収益率:
-12.92
EPS:
-0.61
ネットキャッシュフロー:
$-17.14M
1週間 パフォーマンス:
+0.25%
1か月 パフォーマンス:
-9.63%
6か月 パフォーマンス:
-4.95%
1年 パフォーマンス:
+66.95%
1日の値動き範囲:
$7.66
$8.21
1週間の範囲:
$7.66
$9.00
52週間の値動き範囲:
$4.68
$9.92
Fennec Pharmaceuticals Inc Stock (FENC) Company Profile
名前
Fennec Pharmaceuticals Inc
セクター
電話
(919) 636-4530
住所
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
FENC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FENC
Fennec Pharmaceuticals Inc
|
7.88 | 267.76M | 21.25M | -16.05M | -17.14M | -0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-11-22 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2022-09-07 | 開始されました | CapitalOne | Overweight |
| 2022-08-08 | 再開されました | Craig Hallum | Buy |
| 2020-06-05 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-10-11 | 開始されました | Goldman | Buy |
Fennec Pharmaceuticals Inc (FENC) 最新ニュース
What analysts say about Fennec Pharmaceuticals Inc RV41 stockLarge Cap Stability Picks & Low Risk Investment Portfolio - earlytimes.in
(FRX) Strategic Investment Report (FRX:CA) - news.stocktradersdaily.com
Fennec Pharmaceuticals Completes Full Debt Redemption, Strengthening Financial Position - MSN
Is Fennec Pharmaceuticals Inc. (RV41) stock attractive post correctionTrade Volume Report & Consistent Profit Focused Trading Strategies - newser.com
How Fennec Pharmaceuticals Inc. (RV41) stock performs in volatility spikesWatch List & Daily Entry Point Trade Alerts - newser.com
Will Fennec Pharmaceuticals Inc. stock benefit from commodity pricesJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - newser.com
How Fennec Pharmaceuticals Inc. (RV41) stock trades pre earningsJuly 2025 Action & AI Enhanced Trading Alerts - newser.com
What dividend safety score for Fennec Pharmaceuticals Inc. stockJuly 2025 Fed Impact & High Yield Stock Recommendations - newser.com
Southpoint Capital Advisors LP sells Fennec Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Southpoint Capital Advisors LP sells Fennec Pharmaceuticals shares - Investing.com India
Fennec Pharmaceuticals Closes $5M Private Offering in Canada - MSN
How analysts revise price targets for Fennec Pharmaceuticals Inc. (RV41) stock2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
Can Fennec Pharmaceuticals Inc. (RV41) stock withstand sector downturnsRisk Management & Weekly Chart Analysis and Guides - newser.com
Why Fennec Pharmaceuticals Inc. (RV41) stock is favored by hedge fundsPortfolio Risk Report & Real-Time Market Trend Scan - newser.com
Stocks in play: Fennec Pharmaceuticals Inc. - The Globe and Mail
Can Fennec Pharmaceuticals Inc. stock maintain growth trajectoryJuly 2025 Technicals & Real-Time Volume Analysis Alerts - newser.com
Fennec Pharmaceuticals repays all outstanding convertible notes By Investing.com - Investing.com Nigeria
Will Fennec Pharmaceuticals Inc. (RV41) stock benefit from Fed rate cutsJuly 2025 Action & Smart Allocation Stock Tips - newser.com
Fennec Pharmaceuticals stock rises after repaying all debt By Investing.com - Investing.com Canada
Fennec Pharmaceuticals stock rises after repaying all debt - Investing.com
Can Fennec Pharmaceuticals Inc. stock withstand economic slowdownAnalyst Upgrade & Scalable Portfolio Growth Methods - newser.com
Fennec Pharmaceuticals repays all outstanding convertible notes - Investing.com
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption - The Manila Times
Fennec Pharmaceuticals Brief: Announcing Completion Of Full Debt Redemption - MarketScreener
Can momentum traders help lift Fennec Pharmaceuticals Inc.Weekly Trade Recap & Scalable Portfolio Growth Methods - newser.com
Is Fennec Pharmaceuticals Inc. (RV41) stock cheap vs fundamentals2025 Momentum Check & Real-Time Market Trend Scan - newser.com
Fennec Pharmaceuticals Inc (FENC) 財務データ
収益
当期純利益
現金流量
EPS
Fennec Pharmaceuticals Inc (FENC) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP | 10% Owner |
Nov 14 '25 |
Sale |
8.00 |
160,100 |
1,280,432 |
3,850,000 |
| Southpoint Capital Advisors LP | 10% Owner |
Nov 17 '25 |
Sale |
8.79 |
85,918 |
755,193 |
3,764,082 |
| Raykov Rosty | Director |
Nov 05 '25 |
Sale |
8.10 |
10,000 |
81,000 |
82,318 |
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):